Focus on Milestone Payments, Part I
Executive SummaryThis month, we look at some payments that have been made to biotechs by their large pharmaceutical alliance partners upon early-stage clinical development milestones.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.